Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Many LGBTQ individuals in Lahore face skin issues, with androgenic alopecia, dry skin, and scabies being common, highlighting the need for better healthcare access and provider training.

Gynecologists should learn about transgender care to provide the best service.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.